MGTX |
MeiraGTx Holdings plc |
Aug 12, 2024 |
1 |
$5M |
4 |
Aug 14, 2024 |
Director, 10%+ Owner |
ADGM |
Aja Holdco, Inc. |
Jul 31, 2024 |
0 |
$0 |
3 |
Aug 1, 2024 |
Director, 10%+ Owner |
OBIO |
Orchestra BioMed Holdings, Inc. |
Jul 11, 2024 |
0 |
$0 |
3 |
Jul 17, 2024 |
10%+ Owner |
VAPO |
VAPOTHERM INC |
Jun 17, 2024 |
0 |
$0 |
3 |
Jun 27, 2024 |
10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 14, 2024 |
1 |
$0 |
4 |
Jun 17, 2024 |
Director, 10%+ Owner |
SLDB |
Solid Biosciences Inc. |
Jun 11, 2024 |
1 |
$0 |
4 |
Nov 19, 2024 |
Director, 10%+ Owner |
MGTX |
MeiraGTx Holdings plc |
Jun 6, 2024 |
1 |
$0 |
4 |
Jun 7, 2024 |
Director, 10%+ Owner |
ACRV |
Acrivon Therapeutics, Inc. |
Apr 11, 2024 |
1 |
$20M |
4 |
Apr 15, 2024 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Apr 4, 2024 |
2 |
$834K |
4 |
Apr 8, 2024 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Apr 1, 2024 |
3 |
$1.93M |
4 |
Apr 3, 2024 |
10%+ Owner |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Feb 20, 2024 |
1 |
$0 |
4 |
Feb 21, 2024 |
Director |
LIAN |
LianBio |
Feb 15, 2024 |
6 |
-$3 |
4 |
Feb 20, 2024 |
Director, 10%+ Owner |
ATXS |
Astria Therapeutics, Inc. |
Feb 1, 2024 |
1 |
$30M |
4 |
Feb 5, 2024 |
Director |
SLDB |
Solid Biosciences Inc. |
Jan 11, 2024 |
1 |
$18.9M |
4 |
Jan 12, 2024 |
Director, 10%+ Owner |
VRCA |
Verrica Pharmaceuticals Inc. |
Dec 27, 2023 |
3 |
$2.31M |
4 |
Dec 29, 2023 |
10%+ Owner |
ATHA |
Athira Pharma, Inc. |
Dec 27, 2023 |
3 |
$1.46M |
4 |
Dec 29, 2023 |
Director, 10%+ Owner |
VRCA |
Verrica Pharmaceuticals Inc. |
Dec 21, 2023 |
3 |
$3.26M |
4 |
Dec 26, 2023 |
10%+ Owner |
ATXS |
Astria Therapeutics, Inc. |
Dec 21, 2023 |
1 |
$4.59M |
4 |
Dec 22, 2023 |
Director |
VRCA |
Verrica Pharmaceuticals Inc. |
Dec 15, 2023 |
3 |
$6.94M |
4 |
Dec 19, 2023 |
10%+ Owner |
CRGX |
CARGO Therapeutics, Inc. |
Nov 14, 2023 |
4 |
$10M |
4 |
Nov 14, 2023 |
Former 10% Owner |
CRGX |
CARGO Therapeutics, Inc. |
Nov 9, 2023 |
0 |
$0 |
3 |
Nov 9, 2023 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Oct 16, 2023 |
2 |
-$4.45M |
4 |
Oct 18, 2023 |
10%+ Owner |
ATXS |
Astria Therapeutics, Inc. |
Oct 16, 2023 |
6 |
$26M |
4 |
Oct 18, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Oct 16, 2023 |
1 |
$20M |
4 |
Oct 17, 2023 |
Director |
SLNO |
SOLENO THERAPEUTICS INC |
Sep 26, 2023 |
16 |
$20.1M |
4 |
Sep 28, 2023 |
10%+ Owner |
LIAN |
LianBio |
Jun 21, 2023 |
2 |
$0 |
4 |
Jun 23, 2023 |
Director, 10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director |
MGTX |
MeiraGTx Holdings plc |
Jun 8, 2023 |
2 |
$0 |
4 |
Jun 12, 2023 |
Director, 10%+ Owner |
SLDB |
Solid Biosciences Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director, 10%+ Owner |
SLNO |
SOLENO THERAPEUTICS INC |
Jun 2, 2023 |
3 |
$854K |
4 |
Jun 6, 2023 |
10%+ Owner |
LYRA |
Lyra Therapeutics, Inc. |
May 31, 2023 |
2 |
$9M |
4 |
Jun 2, 2023 |
Director, 10%+ Owner |
SLNO |
SOLENO THERAPEUTICS INC |
May 30, 2023 |
3 |
$188K |
4 |
Jun 1, 2023 |
10%+ Owner |
SLNO |
SOLENO THERAPEUTICS INC |
May 24, 2023 |
3 |
$450K |
4 |
May 26, 2023 |
10%+ Owner |
SLNO |
SOLENO THERAPEUTICS INC |
May 19, 2023 |
3 |
$406K |
4 |
May 23, 2023 |
10%+ Owner |
SLNO |
SOLENO THERAPEUTICS INC |
May 11, 2023 |
0 |
$0 |
3 |
May 18, 2023 |
10%+ Owner |
MGTX |
MeiraGTx Holdings plc |
May 5, 2023 |
1 |
$25M |
4 |
May 15, 2023 |
Director, 10%+ Owner |
CEMI |
CHEMBIO DIAGNOSTICS, INC. |
Apr 4, 2023 |
0 |
$0 |
3 |
Apr 6, 2023 |
10%+ Owner |
VBIV |
VBI Vaccines Inc/BC |
Apr 4, 2023 |
3 |
-$1.48M |
4 |
Apr 6, 2023 |
10%+ Owner |
LABP |
Landos Biopharma, Inc. |
Jan 10, 2023 |
2 |
$16.7M |
4 |
Jan 11, 2023 |
10%+ Owner |
ATXS |
Astria Therapeutics, Inc. |
Dec 19, 2022 |
1 |
$10M |
4 |
Dec 21, 2022 |
Director |
SLDB |
Solid Biosciences Inc. |
Dec 13, 2022 |
1 |
$0 |
4 |
Dec 15, 2022 |
Director, 10%+ Owner |
SLDB |
Solid Biosciences Inc. |
Dec 2, 2022 |
3 |
$15.2M |
4 |
Dec 6, 2022 |
Director, 10%+ Owner |
ACRV |
Acrivon Therapeutics, Inc. |
Nov 17, 2022 |
0 |
$0 |
3 |
Nov 18, 2022 |
10%+ Owner |
QTNT |
Quotient Ltd |
Oct 31, 2022 |
1 |
-$660K |
4 |
Nov 2, 2022 |
10%+ Owner |
ALBO |
ALBIREO PHARMA, INC. |
Oct 11, 2022 |
7 |
-$9.51M |
4 |
Oct 13, 2022 |
10%+ Owner |
LIAN |
LianBio |
Aug 18, 2022 |
1 |
$2.4M |
4 |
Aug 22, 2022 |
Director, 10%+ Owner |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Aug 16, 2022 |
2 |
$150M |
4 |
Aug 18, 2022 |
Director |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 9, 2022 |
2 |
$868K |
4 |
Aug 11, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 8, 2022 |
1 |
$702K |
4 |
Aug 10, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 5, 2022 |
1 |
$980K |
4 |
Aug 9, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 4, 2022 |
1 |
$587K |
4 |
Aug 8, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 3, 2022 |
1 |
$584K |
4 |
Aug 5, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 2, 2022 |
1 |
$2.31M |
4 |
Aug 4, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Aug 1, 2022 |
1 |
$728K |
4 |
Aug 3, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Jul 29, 2022 |
1 |
$1.12M |
4 |
Aug 2, 2022 |
10%+ Owner |
ALDX |
Aldeyra Therapeutics, Inc. |
Jul 28, 2022 |
1 |
$597K |
4 |
Aug 1, 2022 |
10%+ Owner |
VRCA |
Verrica Pharmaceuticals Inc. |
Jul 5, 2022 |
1 |
$3M |
4 |
Jul 5, 2022 |
10%+ Owner |
ATHA |
Athira Pharma, Inc. |
Jun 29, 2022 |
2 |
$4.1M |
4 |
Jul 1, 2022 |
Director, 10%+ Owner |
LIAN |
LianBio |
Jun 23, 2022 |
2 |
$0 |
4 |
Jun 27, 2022 |
Director, 10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 17, 2022 |
Director, 10%+ Owner |
MGTX |
MeiraGTx Holdings plc |
Jun 7, 2022 |
2 |
$0 |
4 |
Jun 13, 2022 |
Director, 10%+ Owner |
SLDB |
Solid Biosciences Inc. |
Jun 7, 2022 |
1 |
$0 |
4 |
Jun 9, 2022 |
Director, 10%+ Owner |
LIAN |
LianBio |
May 26, 2022 |
1 |
$216K |
4 |
May 27, 2022 |
Director, 10%+ Owner |
LIAN |
LianBio |
May 23, 2022 |
3 |
$442K |
4 |
May 25, 2022 |
Director, 10%+ Owner |
ATHA |
Athira Pharma, Inc. |
May 20, 2022 |
1 |
$0 |
4 |
May 27, 2022 |
Director, 10%+ Owner |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Apr 18, 2022 |
1 |
$3.5M |
4 |
Apr 18, 2022 |
10%+ Owner |
LYRA |
Lyra Therapeutics, Inc. |
Apr 12, 2022 |
1 |
$25M |
4 |
Apr 14, 2022 |
Director, 10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Dec 8, 2021 |
1 |
$1.07M |
4 |
Dec 10, 2021 |
Director |
VBIV |
VBI Vaccines Inc/BC |
Dec 1, 2021 |
1 |
-$8.96M |
4 |
Dec 3, 2021 |
10%+ Owner |
LIAN |
LianBio |
Nov 3, 2021 |
2 |
$36.3M |
4 |
Nov 5, 2021 |
Director, 10%+ Owner |
LIAN |
LianBio |
Nov 1, 2021 |
12 |
$3.21M |
4 |
Nov 3, 2021 |
Director, 10%+ Owner |
LIAN |
LianBio |
Oct 29, 2021 |
0 |
$0 |
3 |
Oct 29, 2021 |
Director, 10%+ Owner |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Oct 25, 2021 |
1 |
$23.8M |
4 |
Oct 25, 2021 |
10%+ Owner |
AGRX |
AGILE THERAPEUTICS INC |
Oct 13, 2021 |
2 |
$4.87M |
4 |
Oct 15, 2021 |
10%+ Owner |
ISO |
IsoPlexis Corp |
Oct 12, 2021 |
7 |
$12.8M |
4 |
Oct 14, 2021 |
10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Oct 7, 2021 |
7 |
-$667K |
4 |
Oct 13, 2021 |
10%+ Owner |
ISO |
IsoPlexis Corp |
Oct 7, 2021 |
0 |
$0 |
3 |
Oct 7, 2021 |
10%+ Owner |
ADMA |
ADMA BIOLOGICS, INC. |
Sep 28, 2021 |
3 |
-$299K |
4 |
Sep 30, 2021 |
10%+ Owner |
ADMA |
ADMA BIOLOGICS, INC. |
Sep 24, 2021 |
2 |
-$623K |
4 |
Sep 29, 2021 |
10%+ Owner |
LPTX |
LEAP THERAPEUTICS, INC. |
Sep 24, 2021 |
1 |
$10M |
4 |
Sep 28, 2021 |
10%+ Owner |
ADMA |
ADMA BIOLOGICS, INC. |
Sep 23, 2021 |
1 |
-$991K |
4 |
Sep 28, 2021 |
10%+ Owner |
LABP |
Landos Biopharma, Inc. |
Aug 27, 2021 |
1 |
$0 |
4 |
Aug 31, 2021 |
Director, 10%+ Owner |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Aug 26, 2021 |
1 |
$2.06M |
4 |
Aug 31, 2021 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Aug 23, 2021 |
3 |
$4.83M |
4 |
Aug 25, 2021 |
Director |
ADMA |
ADMA BIOLOGICS, INC. |
Aug 17, 2021 |
3 |
-$2.33M |
4 |
Aug 19, 2021 |
10%+ Owner |
VYNE |
VYNE Therapeutics Inc. |
Aug 16, 2021 |
1 |
-$435K |
4 |
Aug 18, 2021 |
10%+ Owner |
VYNE |
VYNE Therapeutics Inc. |
Aug 13, 2021 |
1 |
-$460K |
4 |
Aug 17, 2021 |
10%+ Owner |
VYNE |
VYNE Therapeutics Inc. |
Aug 12, 2021 |
1 |
-$756K |
4 |
Aug 16, 2021 |
10%+ Owner |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jul 7, 2021 |
1 |
$5M |
4 |
Jul 9, 2021 |
Director |
VBIV |
VBI Vaccines Inc/BC |
Jun 29, 2021 |
2 |
-$2.46M |
4 |
Jun 30, 2021 |
10%+ Owner |
MGTX |
MeiraGTx Holdings plc |
Jun 10, 2021 |
2 |
$0 |
4 |
Jun 14, 2021 |
Director, 10%+ Owner |
VBIV |
VBI Vaccines Inc/BC |
Jun 9, 2021 |
6 |
-$1K |
4 |
Jun 11, 2021 |
10%+ Owner |
NAUT |
ARYA Sciences Acquisition Corp III |
Jun 3, 2021 |
1 |
$3.32M |
4 |
Jun 3, 2021 |
Director |
ATHA |
Athira Pharma, Inc. |
May 28, 2021 |
1 |
$0 |
4 |
Jun 1, 2021 |
Director |
NAUT |
Nautilus Biotechnology, Inc. |
May 24, 2021 |
3 |
$55.1M |
4 |
Jun 11, 2021 |
Former Director |
NAUT |
ARYA Sciences Acquisition Corp III |
May 20, 2021 |
1 |
$1.61M |
4 |
May 24, 2021 |
Director |
NAUT |
ARYA Sciences Acquisition Corp III |
May 20, 2021 |
0 |
$0 |
3 |
May 24, 2021 |
Director |
VYNE |
VYNE Therapeutics Inc. |
May 6, 2021 |
1 |
-$3.67M |
4 |
May 7, 2021 |
10%+ Owner |